Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Market wrap (05.08.2026)
AMD Did Everything Right… But Only Right
SpaceX Shares Drop 6% After Earnings 🚩 Is Space No Longer Enough for Wall Street?
Daily Summary: Nasdaq 100 Up 3.2% – Is the Bull Market Back? (04.08.2026)